Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
This article has been cited by
1Second-line treatment of metastatic gastric cancer: Current options and future directions
Dheepak Kanagavel
World Journal of Gastroenterology.2015;21(41)11621
[DOI]
2Clinical Assessment of 5-Fluorouracil/Leucovorin, Nab-Paclitaxel, and Irinotecan (FOLFIRABRAX) in Untreated Patients with Gastrointestinal Cancer Using UGT1A1 Genotype–Guided Dosing
Smita S. Joshi,Daniel V.T. Catenacci,Theodore G. Karrison,Jaclyn D. Peterson,Mark M. Zalupski,Amikar Sehdev,James Wade,Ahad Sadiq,Vincent J. Picozzi,Andrea Amico,Robert Marsh,Mark F. Kozloff,Blase N. Polite,Hedy L. Kindler,Manish R. Sharma
Clinical Cancer Research.2020;26(1)18
[DOI]
3Dual PI3K/mTOR inhibitor BEZ235 as a promising therapeutic strategy against paclitaxel-resistant gastric cancer via targeting PI3K/Akt/mTOR pathway
Dongshao Chen,Xiaoting Lin,Cheng Zhang,Zhentao Liu,Zuhua Chen,Zhongwu Li,Jingyuan Wang,Beifang Li,Yanting Hu,Bin Dong,Lin Shen,Jiafu Ji,Jing Gao,Xiaotian Zhang
Cell Death & Disease.2018;9(2)18
[DOI]

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal